Zonisamide Capsule
FDA Label NDC 70771-1142

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Zonisamide (NDC 70771-1142). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding spl medguide, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Spl Medguide

Manufactured by:

Cadila Healthcare Ltd.

India

Package Label.Principal Display Panel

NDC 70771-1142-1 in bottle of 100 Capsules

Zonisamide Capsules, 25 mg

Rx only

100 Capsules

Zonisamide Capsules, 25 mg (A140305e 5978 48b1 8a43 3945ca59b2d0 03)

Zonisamide Capsules, 25 mg (A140305e 5978 48b1 8a43 3945ca59b2d0 03)

NDC 70771-1143-1 in bottle of 100 Capsules

Zonisamide Capsules, 50 mg

Rx only

100 Capsules

Zonisamide Capsules, 50 mg (A140305e 5978 48b1 8a43 3945ca59b2d0 04)

Zonisamide Capsules, 50 mg (A140305e 5978 48b1 8a43 3945ca59b2d0 04)

NDC 70771-1144-1 in bottle of 100 Capsules

Zonisamide Capsules, 100 mg

Rx only

100 Capsules

Zonisamide Capsules, 100 mg (A140305e 5978 48b1 8a43 3945ca59b2d0 05)

Zonisamide Capsules, 100 mg (A140305e 5978 48b1 8a43 3945ca59b2d0 05)

* Please review the disclaimer below.